Diadema Partners LP Ocular Therapeutix, Inc Transaction History
Diadema Partners LP
- $233 Billion
- Q4 2024
A detailed history of Diadema Partners LP transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Diadema Partners LP holds 104,000 shares of OCUL stock, worth $728,000. This represents 0.38% of its overall portfolio holdings.
Number of Shares
104,000Holding current value
$728,000% of portfolio
0.38%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding OCUL
# of Institutions
190Shares Held
132MCall Options Held
374KPut Options Held
179K-
Summer Road LLC West Palm Beach, FL13.9MShares$97.1 Million98.85% of portfolio
-
Deep Track Capital, LP Greenwich, CT12.8MShares$89.9 Million4.83% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$89.3 Million17.98% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$80.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.48MShares$59.4 Million0.0% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $539M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...